Efficacy and safety of PD-1/PD-L1 inhibitors plus nab-paclitaxel for patients with non-small cell lung cancer who have progressed after platinum-based chemotherapy.
Zhang F, Huang D, Zhao L, Li T, Zhang S, Zhang G, Yuan F, Zhang J, Zhang Y, Zhao Z, Cui L, Zhao J, Wang G, Cai S, Bai Y, Wang J, Hu Y.
Zhang F, et al. Among authors: wang g, wang j.
Ther Adv Med Oncol. 2020 Jul 6;12:1758835920936882. doi: 10.1177/1758835920936882. eCollection 2020.
Ther Adv Med Oncol. 2020.
PMID: 32670420
Free PMC article.